Figure 6
From: RNA editing signature during myeloid leukemia cell differentiation
ADAR1 silencing in PMA-treated U-937 cells does not influence differentiation or ADAR2 activity. (a) Expression of the differentiation markers CD11B, CD14 and CD54 in the two si-ADAR1 clones undergoing PMA treatment. (b) Variation of ADAR1 mRNA expressed as log2-fold increase in the scramble (scr) and in the two transfected U-937 clones. (c) Variation in ADAR1, ADAR2 and GFP protein expression in the scramble and in the two si-ADAR1 clones.
